INmune Bio
INMB
INMB
32 hedge funds and large institutions have $18.2M invested in INmune Bio in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 12 increasing their positions, 9 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
6% less funds holding
Funds holding: 34 → 32 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Holders
32
Holding in Top 10
–
Calls
$590K
Puts
$426K
Top Buyers
| 1 | +$1.62M | |
| 2 | +$359K | |
| 3 | +$124K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$100K |
| 5 |
Millennium Management
New York
|
+$95.6K |
Top Sellers
| 1 | -$269K | |
| 2 | -$137K | |
| 3 | -$135K | |
| 4 |
Squarepoint
New York
|
-$84.3K |
| 5 |
FAIM
Financial Advocates Investment Management
Olympia,
Washington
|
-$74.3K |